Rectal Insert TAF/EVG Pre-Exposure Prophylaxis (RITE PrEP) Study

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 16, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

May 16, 2025

Conditions
Safety Issues
Interventions
DRUG

TAF/EVG rectal insert

Phase 1: rectal inserts applied daily for 3 consecutive days Phase 2: rectal inserts applied every other day for 14 days

DRUG

Matching placebo rectal insert

Phase 1: rectal inserts applied daily for 3 consecutive days Phase 2: rectal inserts applied every other day for 14 days

Trial Locations (1)

30322

Emory Clinic, Atlanta

All Listed Sponsors
collaborator

CONRAD

OTHER

collaborator

Emory University

OTHER

collaborator

Centers for Disease Control and Prevention

FED

lead

Eastern Virginia Medical School

OTHER

NCT06274398 - Rectal Insert TAF/EVG Pre-Exposure Prophylaxis (RITE PrEP) Study | Biotech Hunter | Biotech Hunter